Cargando…

The importance of provocation tests with COX2 inhibitors on patients with a history of cross-hypersensitivity to non-steroidal anti-inflammatory (NSAIDs)

Detalles Bibliográficos
Autor principal:	Gonçalves, Tania Tavares
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407095/ http://dx.doi.org/10.1186/1939-4551-8-S1-A213

Ejemplares similares

Safety of meloxicam oral provocation challenge in patients with NSAID reaction
por: Morales, Cristina Isabel Herrera, et al.
Publicado: (2015)

Hypersensitivity to non-steroidal anti-inflammatory drugs in pediatric patients
por: Lacerda, Alex, et al.
Publicado: (2015)

Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
por: Thalappil, Sherin, et al.
Publicado: (2022)

Practical Approach to Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Children
por: Podlecka, Daniela, et al.
Publicado: (2023)

Pro and Contra: Provocation Tests in Drug Hypersensitivity
por: Soyer, Ozge, et al.
Publicado: (2017)

Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs): classification of a Danish patient cohort according to EAACI/ENDA guidelines
por: Nissen, Christoffer V, et al.
Publicado: (2015)

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
por: Kushner, Pamela, et al.
Publicado: (2022)

Diagnostic Value of Oral Provocation Tests in Drug Hypersensitivity Reactions Induced by Nonsteroidal Anti-Inflammatory Drugs and Paracetamol
por: Popiolek, Iwona, et al.
Publicado: (2022)

Provocation test in patients with different phenotypes of aspirin hypersensitivity
por: Specjalski, Krzysztof, et al.
Publicado: (2013)

Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review
por: Sohail, Rohab, et al.
Publicado: (2023)

Relative Value of the NSAIDs, Including COX-2 Inhibitors and Meloxicam
por: Curtiss, Frederic R.
Publicado: (2006)

Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium
por: Konovalova, Irina S., et al.
Publicado: (2021)

Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
por: Khan, Shanzana, et al.
Publicado: (2019)

Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
por: Bruce, Eilidh, et al.
Publicado: (2020)

The Psychological Relieving Effect of Drug Provocation Test in Drug Hypersensitivity
por: Rhyou, Hyo-In, et al.
Publicado: (2022)

SIAIP position paper: provocation challenge to antibiotics and non-steroidal anti-inflammatory drugs in children
por: Caffarelli, Carlo, et al.
Publicado: (2018)

Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2021)

Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors
por: Ahmadi, Mohsen, et al.
Publicado: (2022)

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
por: Bindu, Samik, et al.
Publicado: (2020)

Non-steroidal Anti-inflammatory Drugs (NSAIDs) Systemic Use: The Risk of Renal Failure
por: Bensman, Albert
Publicado: (2020)

Prevalence of non‐steroidal anti‐inflammatory drugs (NSAIDs) use in patients with hypertensive crisis
por: Jahangiri, Soodeh, et al.
Publicado: (2022)

Origins of cancer: tackling provocative questions
por: Solitro, Abigail R., et al.
Publicado: (2017)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity
por: Goh, Si Hui, et al.
Publicado: (2021)

Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity
por: Terzioğlu, Kadriye, et al.
Publicado: (2020)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

Post exposition to etoricoxib in patients with negative oral drug provocation tests
por: Sterza, Thais, et al.
Publicado: (2015)

Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension
por: Aljadhey, Hisham, et al.
Publicado: (2012)

Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2013)

Non-steroidal anti-inflammatory drugs (NSAIDs) and neuroprotection in the elderly: a view from the mitochondria
por: Calvo-Rodríguez, María, et al.
Publicado: (2015)

Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity
por: Abuaf, N., et al.
Publicado: (2012)

When to stop anticoagulation, anti-platelet aggregates, and non-steroidal anti-inflammatories (NSAIDs) prior to spine surgery
por: Epstein, Nancy E.
Publicado: (2019)

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs
por: Scheiman, James M, et al.
Publicado: (2005)

Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
por: Gao, Feng, et al.
Publicado: (2018)

Importance of a second spasm provocation test: Four cases with an initial negative spasm provocation test
por: Teragawa, Hiroki, et al.
Publicado: (2017)

375 Non-steroidal Anti-inflammatory Drugs Hypersensitivity: Patterns of Reaction
por: Chiaverini Ensina, Luis Felipe, et al.
Publicado: (2012)

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial
por: Bickham, Kara, et al.
Publicado: (2016)

Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
por: McCarthy, D. M.
Publicado: (1998)

The Inhibitory Effect of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on the Monophenolase and Diphenolase Activities of Mushroom Tyrosinase
por: Sato, Kazuomi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pbsq908gu6bbkb4q9kbau8ulsl